Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man.

PubWeight™: 1.97‹?› | Rank: Top 2%

🔗 View Article (PMID 5943767)

Published in Am J Dig Dis on August 01, 1966

Authors

H Sprinz, E J Gangarosa, M Williams, R B Hornick, T E Woodward

Articles citing this

The route of enteric infection in normal mice. J Exp Med (1974) 7.99

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16

The Salmonella enterica serotype typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect Immun (2002) 2.88

Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea. Infect Immun (2003) 2.25

The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun (2005) 1.72

The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect Immun (2007) 1.69

Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun (2006) 1.50

How to become a top model: impact of animal experimentation on human Salmonella disease research. Infect Immun (2011) 1.40

Secreted effector proteins of Salmonella enterica serotype typhimurium elicit host-specific chemokine profiles in animal models of typhoid fever and enterocolitis. Infect Immun (2003) 1.35

Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ. Front Microbiol (2014) 1.25

Taming the elephant: Salmonella biology, pathogenesis, and prevention. Infect Immun (2010) 1.14

Immunoglobulin-containing cells in the small intestine during acute enteritis. Gut (1972) 1.11

The capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1-independent mechanism. Infect Immun (2009) 1.10

Appraisal of typhoid vaccine in experimentally infected human subjects. Trans Am Clin Climatol Assoc (1967) 1.10

Typhoid fever: "you can't hit what you can't see". Gut Microbes (2012) 1.02

Host restriction of Salmonella enterica serotype Typhi is not caused by functional alteration of SipA, SopB, or SopD. Infect Immun (2005) 1.01

Salmonella enterica Serovar Typhi conceals the invasion-associated type three secretion system from the innate immune system by gene regulation. PLoS Pathog (2014) 0.93

Gastrointestinal tract distribution of Salmonella enteritidis in orally infected mice with a species-specific fluorescent quantitative polymerase chain reaction. World J Gastroenterol (2007) 0.86

Pathobiology of salmonella, intestinal microbiota, and the host innate immune response. Front Immunol (2014) 0.86

Small bowel in typhoid fever. Gut (1971) 0.84

Effective treatment and prevention of typhoid fever: updated. Trans Am Clin Climatol Assoc (1984) 0.80

Tolerance of young children with severe gastroenteritis to dietary lactose: a controlled study. Can Med Assoc J (1968) 0.80

Differences in Host Cell Invasion and Salmonella Pathogenicity Island 1 Expression between Salmonella enterica Serovar Paratyphi A and Nontyphoidal S. Typhimurium. Infect Immun (2016) 0.77

Infectious disease emergencies. Part IV: Patients presenting with gastrointestinal disorders. West J Med (1977) 0.75

Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity. Ecosal Plus (2016) 0.75

Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in Humans. Cell Mol Gastroenterol Hepatol (2017) 0.75

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36

Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet (1978) 10.29

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24

Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52

Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis (1974) 6.38

Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32

Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95

Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet (1975) 4.85

A Critical Study of the Methods of Estimating Cholesterol and Allied Substances. Biochem J (1921) 4.58

Experimental bacillary dysentery. An electron microscopic study of the response of the intestinal mucosa to bacterial invasion. Am J Pathol (1965) 4.42

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41

Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J (2001) 4.40

Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med (1978) 4.28

Chloromycetin in the Treatment of Scrub Typhus. Science (1948) 4.23

Lymphocyte trafficking and regional immunity. Adv Immunol (1999) 4.21

[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18

Distribution of NHS funds between fundholding and non-fundholding practices. BMJ (1994) 4.05

Fecal leukocytes in diarrheal illness. Ann Intern Med (1972) 3.89

Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77

Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75

Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis (1989) 3.71

A case of cholera in Texas, 1973. Am J Epidemiol (1974) 3.71

Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45

Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969. J Infect Dis (1970) 3.41

Enrichment of gene-coding sequences in maize by genome filtration. Science (2003) 3.41

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet (1985) 3.32

Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ (1996) 3.18

AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation (2000) 3.05

Impact in the United States of the Shiga dysentery pandemic of Central America and Mexico: a review of surveillance data through 1972. J Infect Dis (1974) 2.91

Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science (1977) 2.88

The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum. J Infect Dis (1972) 2.87

Scombroid fish poisoning. Outbreak traced to commercially canned tuna fish. JAMA (1974) 2.84

Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry (2001) 2.83

Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80

Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis (1974) 2.73

Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrob Agents Chemother (1976) 2.71

Final results from a meta-analysis of remedial interventions with drink/drive offenders. Addiction (1995) 2.66

Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63

Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57

Adverse effect of lomotil therapy in shigellosis. JAMA (1973) 2.57

Exerimental acute colitis in the Rhesus monkey following peroral infection with Shigella flexneri. An electron microscope study. Am J Pathol (1968) 2.53

Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg (1979) 2.51

Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun (1977) 2.49

Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46

Aerogenic immunization of man with live Tularemia vaccine. Bacteriol Rev (1966) 2.42

Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer (1998) 2.36

International outbreak of Salmonella Eastbourne infection traced to contaminated chocolate. Lancet (1975) 2.32

Shigella surveillance in the United States, 1975. J Infect Dis (1977) 2.31

Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain. JAMA (1968) 2.30

Immunity to enterotoxigenic Escherichia coli. Infect Immun (1979) 2.30

Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29

Detection of Vibrio cholerae biotype El Tor by purging. Bull World Health Organ (1966) 2.27

Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med (1984) 2.24

Invasive Escherichia coli. J Infect Dis (1978) 2.19

CHLORAMPHENICOL (CHLOROMYCETIN) IN THE TREATMENT OF TSUTSUGAMUSHI DISEASE (SCRUB TYPHUS). J Clin Invest (1949) 2.19

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry (1998) 2.16

Incentive spirometry decreases respiratory complications following major abdominal surgery. Surgeon (2007) 2.15

Turtle-associated salmonellosis. I. An estimation of the magnitude of the problem in the United States, 1970-1971. Am J Epidemiol (1972) 2.15

Possible discrimination in recruitment of psychiatry residents? Am J Psychiatry (1997) 2.14

The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest (1990) 2.12

Penetration of erythrocytes by merozoites of mammalian and avian malarial parasites. J Parasitol (1969) 2.12

Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J Affect Disord (1998) 2.10

Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature (1968) 2.10

Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci (1997) 2.09

Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 2.08

The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bull N Y Acad Med (1971) 2.07

Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res (2001) 2.05

British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05

Electron-Microscope Studies of Experimental Salmonella Infection in the Preconditioned Guinea Pig: II. Response of the Intestinal Mucosa to the Invasion by Salmonella typhimurium. Am J Pathol (1967) 2.04

Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02

The segment polarity gene armadillo interacts with the wingless signaling pathway in both embryonic and adult pattern formation. Development (1991) 2.01

Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem (1992) 2.01

The feeding mechanism of avian malarial parasites. J Cell Biol (1966) 2.00

Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99

CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther (1989) 1.99

Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol (1987) 1.97

The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97

Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J (1996) 1.93

Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride. JAMA (1968) 1.93

Morphological effects of chloroquine on Plasmodium berghei in mice. Nature (1967) 1.92

Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol (1969) 1.91

Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J (1999) 1.90

Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science (1998) 1.87

P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther (2000) 1.85

Food poisoning due to Vibrio parahaemolyticus. Annu Rev Med (1974) 1.85

Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull World Health Organ (1971) 1.84

Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci (1973) 1.84

Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83

Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation. Lancet (1967) 1.83

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet (1998) 1.83

Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82

Comparison of media for direct isolation and transport of Shigellae from Fecal specimens. Appl Microbiol (1970) 1.82